2B77:XETRA:XETRA-iShares Ageing Population UCITS Acc (EUR)

ETF | Others |

Last Closing

USD 7.764

Change

+0.07 (+0.84)%

Market Cap

USD 0.50B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.47 (+0.88%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.58%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.70%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.10 (+0.34%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.08 (+0.30%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.39 (-0.84%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

-2.60 (-1.81%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.31 (+0.59%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.24 (-0.22%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.82 (-0.46%)

USD 80.38B

ETFs Containing 2B77:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.45% 90% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.45% 90% A- 85% B
Trailing 12 Months  
Capital Gain 21.35% 78% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.35% 77% C+ 75% C
Trailing 5 Years  
Capital Gain 35.05% 60% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.05% 55% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 8.77% 59% D- 59% D-
Dividend Return 8.77% 57% F 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.77% 32% F 44% F
Risk Adjusted Return 55.58% 47% F 53% F
Market Capitalization 0.50B 66% D+ 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.